Riskpilot← Back to searchSign inGet full accessTeaMed Oy
OYDissolvedY-tunnus 3130178-9Jylhänkuja 8Medical specialists activities · NACE 8622Est. 20201 employees
Revenue 2025
EUR 242K
+19% vs 2024
EBITDA margin
13.3%
-48% vs 2024
Equity ratio
87.2%
Financial strength
Net profit 2025
EUR 15K
-64% vs 2024
| Revenue | EUR 242K | +19% |
| EBITDA | EUR 32K | -48% |
| Net profit | EUR 15K | -64% |
| Total assets | EUR 65K | +12% |
| Equity | EUR 57K | +24% |
| Employees | 1 | — |
Legal name
TeaMed Oy
Y-tunnus number
3130178-9
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
7. huhtikuuta 2020
Share capital
EUR 0
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on terveydenhuolto- ja lääkäripalvelut. Yhtiö voi toimintaansa varten omistaa ja hallita kiinteistöjä sekä kiinteistöyhtiöiden että muiden yhtiöiden osakkeita ja yhtiöosuuksia.
Address
Jylhänkuja 8
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 91 | 164 | 134 | 202 | 242 |
| Staff expenses | −40 | −74 | −66 | −74 | −120 |
| EBITDA | 6 | 24 | −2 | 61 | 32 |
| Depreciation & amort. | — | −9 | −7 | −13 | −11 |
| EBIT | 6 | 15 | −8 | 48 | 22 |
| Net financials | −0 | −1 | −0 | 0 | −2 |
| Profit before tax | 6 | 14 | −8 | 48 | 20 |
| Tax | −0 | 4 | −0 | 8 | 5 |
| Net profit | 6 | 10 | −8 | 40 | 15 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 50 | 37 | 29 | 58 | 65 |
| Equity | 15 | 16 | 6 | 46 | 57 |
| Long-term debt | 24 | 0 | −9 | 0 | 0 |
| Short-term debt | 11 | 22 | 32 | 12 | 8 |
| Total debt | 35 | 22 | 23 | 12 | 8 |
EBITDA margin
13.3%
This company
15.8%
Market median
-16% vs market
20212025
Equity ratio
87.2%
This company
38.2%
Market median
+128% vs market
20212025
Return on equity
25.6%
This company
18.4%
Market median
+39% vs market
20212025
Net profit margin
6.0%
This company
8.1%
Market median
-26% vs market
20212025
Asset turnover
3.73×
This company
1.12×
Market median
+233% vs market
20212025
Debt / equity
0.15×
This company
0.62×
Market median
+76% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-09-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via PRH / YTJ · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via PRH / YTJ · Period 2020-04-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JR Deputy Member | Deputy Member | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of TeaMed Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Juha Risto Kuittinen | Deputy Member | 0 companies |
| Tea Inkeri Kuittinen | Board of Directors | 0 companies |